Carl E. Ruby
Impact in
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immune Response and Inflammation
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Immunology 23
- Immunotherapy and Immune Responses 16
- Immune Cell Function and Interaction 14
- T-cell and B-cell Immunology 12
- Immune Response and Inflammation 5
- Oncology 7
- CAR-T cell therapy research 5
- Cancer Immunotherapy and Biomarkers 3
- Co-authors
- Andrew D. Weinberg (13 shared papers)William L. Redmond (4 shared papers)Howard L. Kaufman (11 shared papers)Tasha M. Hughes (3 shared papers)Craig Lee Slingluff (1 shared paper)Nancy Isaacson Kerkvliet (3 shared papers)Michael J. Gough (2 shared papers)Birat Dhungel (1 shared paper)
- Journals
- The Journal of Immunology (5 papers)Cancer Immunology Immunotherapy (3 papers)Journal for ImmunoTherapy of Cancer (3 papers)Journal of Medical Microbiology (2 papers)European Journal of Immunology (2 papers)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Carl E. Ruby
35 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 90
- Immunology 1.0k
- Oncology 681
- Virology 73
- Cancer Research 137
- Biotechnology 80
Countries citing papers authored by Carl E. Ruby
This map shows the geographic impact of Carl E. Ruby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl E. Ruby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl E. Ruby more than expected).
Fields of papers citing papers by Carl E. Ruby
This network shows the impact of papers produced by Carl E. Ruby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl E. Ruby. The network helps show where Carl E. Ruby may publish in the future.
Co-authors
The 25 scholars most cited alongside Carl E. Ruby, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 182 | |
| 2 | 2009 | 171 | |
| 3 | 2008 | 149 | |
| 4 | 2009 | 134 | |
| 5 | 2010 | 121 | |
| 6 | 2013 | 97 | |
| 7 | 2007 | 87 | |
| 8 | 2006 | 83 | |
| 9 | 2006 | 82 | |
| 10 | 2017 | 67 | |
| 11 | 2008 | 61 | |
| 12 | 2013 | 59 | |
| 13 | 2002 | 55 | |
| 14 | 2015 | 53 | |
| 15 | 2018 | 44 | |
| 16 | 2009 | 39 | |
| 17 | 2002 | 35 | |
| 18 | 2015 | 35 | |
| 19 | 2014 | 34 | |
| 20 | 2014 | 32 |
About Carl E. Ruby
Carl E. Ruby is a scholar working on Immunology, Oncology, Cancer Research, Molecular Biology and Biotechnology, having authored 35 papers that have together received 1.8k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (16 papers), Immune Cell Function and Interaction (14 papers), T-cell and B-cell Immunology (12 papers), CAR-T cell therapy research (5 papers), Immune Response and Inflammation (5 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Extracellular vesicles in disease (3 papers). The work is most often cited by research in Immunology (1.0k citations), Oncology (681 citations), Virology (73 citations), Cancer Research (137 citations) and Biotechnology (80 citations). Carl E. Ruby has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Andrew D. Weinberg, William L. Redmond, Howard L. Kaufman, Tasha M. Hughes, Craig Lee Slingluff, Nancy Isaacson Kerkvliet, Michael J. Gough, Birat Dhungel, Daniel P. Haley and Joseph R. Maxwell. Their work appears in journals such as The Journal of Immunology, Cancer Immunology Immunotherapy, Journal for ImmunoTherapy of Cancer, Journal of Medical Microbiology and European Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.